NEW PEPTIDES AS SELECTIVE IL-23 RECEPTOR ANTAGONISTS

The present disclosure relates to peptide IL23 receptor antagonists, their pharmaceutical compositions and their medical use, for example in the treatment of inflammatory bowel diseases such as Crohn's disease. La présente invention concerne des antagonistes peptidiques du récepteur de l'I...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KURZ, Michael, BOEHME, Thomas, HAACK, Torsten, WAGNER, Michael, PETRY, Stefan, PÖVERLEIN, Christoph, BESENIUS, Melissa, TIWARI, Garima
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to peptide IL23 receptor antagonists, their pharmaceutical compositions and their medical use, for example in the treatment of inflammatory bowel diseases such as Crohn's disease. La présente invention concerne des antagonistes peptidiques du récepteur de l'IL-23 , leurs compositions pharmaceutiques et leur utilisation médicale, par exemple dans le traitement de maladies intestinales inflammatoires telles que la maladie de Crohn.